The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Galena Mining (G1A) produces first concentrate at the Abra base metals mine in the Gascoyne region of Western Australia
  • The company told investors commissioning of the processing plant is progressing quickly and concentrate production shows initial process flow continuity
  • G1A says its focus will remain on achieving the plant’s processing design criteria in the first quarter of the 2023 calendar year
  • The company is also targeting its first product shipment date this quarter
  • Galena Mining is up 5.56 per cent, trading at 28.5 cents at midday AEDT

Galena Mining (G1A) has produced first concentrate at the Abra base metals mine in the Gascoyne region of Western Australia.

The mine is 60 per cent held by Galena, with the remaining 40 per cent held by Toho Zinc.

The company has been focusing on its Abra mine, with practical completion of the plant achieved ahead of schedule on December 23 2022, closely followed by ore commissioning, which commenced on January 9.

The ore commissioning of the plant took place under the guidance of GR Engineering, with the aim of completion by the end of the month. This will include completion of punch list items and performance testing.

“Commissioning of the processing plant is progressing quickly and concentrate production shows initial process flow continuity,” Galena Managing Director Tony James said.

The Managing Director told investors the company will continue with commissioning through January, with the focus on achieving the plant’s processing design criteria in the first quarter of the 2023 calendar year.

Galena also aims to produce its first product shipment during this quarter.

Galena Mining was up 5.56 per cent, trading at 28.5 cents at midday AEDT.  

G1A by the numbers
More From The Market Online
A Red Sky Energy rig out in the ocean.

Red Sky Energy bleeds more than 18% after ‘landmark’ Angola block entry

Red Sky Energy was ready to pop champagne after being awarded 35% in a "transformative" Angola…
A patient being dosed with Imugene Limited testing materials.

First Aussie doses bring Imugene major step closer to ‘quicker, cheaper’ non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic
A market trading board with ASX marked on the side.

‘Shine a light’: ASX to get more aggressive on companies ‘not up to scratch’ on disclosures

The Australian Securities Exchange (ASX:ASX) will be taking poor disclosure from market-listed companies far more seriously through this next
The words "Market Open" appear stacked atop one another next to ASX company iconography.

ASX Market Open: Ever-extending US loss streak to bleed into red Friday – unless Oz bucks trend again | Jan 3, 2024

The ASX 200 is expected to open 0.07% lower at 8,185 points, though after